Eculizumab is an effective treatment for patients with atypical hemolytic syndrome (aHUS) receiving chronic plasma therapy (PT)

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Goodship TH, Muus P, Legendre CM, Douglas K, Hourmant M, Delmas Y, Herthelius BM, Trivelli A, Loirat C, Bedrosian C, Licht C

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: British Journal of Haematology: 51st Annual Scientific Meeting of the British Society for Haematology

Year of Conference: 2011

Pages: 24 abstract no. 49

ISSN: 0007-1048

Publisher: Wiley-Blackwell Publishing Ltd.

URL: .

Library holdings: Search Newcastle University Library for this item

ISBN: 13652141

ePrints